Skip to main content Skip to section navigation
Back to Top

Researchers in our department are transforming mental health research and mental illness treatment globally. We are driving some of the most exciting advances in neuroscience and psychiatry achieving a global influence through discovery, innovation, translation, and implementation.

One in four individuals will suffer from mental illness during their lives. In terms of individual and societal costs, the burden of mental illness greatly exceeds that of any other class of illness.

At Stanford, the future is now. The Department of Psychiatry and Behavioral Sciences sits at the nexus of discovery and innovation. We embrace the dynamic nature of the Silicon Valley and our place in this environment. We constantly challenge ourselves to be at the forefront of high-impact, multidisciplinary development to foster and improve the health and wellbeing of persons living with mental illness, intellectual and developmental disorders, and addiction. It is only through the continual process of exploration, evaluation, and refinement that we can provide best-in-class treatments and options for those who need them the most. We thrive in this fast-paced environment and derive strength from it.

We work with rapid and focused movement along this translational science and clinical research model in order to accelerate discovery, innovate dissemination and implementation, and coordinate these efforts across the five mission areas of our Department, selecting points of maximal influence for strategic impact to the populations and communities we serve.

340+

Actively funded projects & agreements in FY25

900+

Scholarly publications by department faculty in 2025

145

Postdoctoral Scholars

Journal Articles

A sample of recent publications co-authored by faculty in our department

  • Journal Articles October 31, 2026
    Standardizing wearable sleep data for clinical, research, and public health use: A World Sleep Society specification.

    Chee MWL, Baumert M, Drummond SPA, Scott H, Goldstein CA, de Zambotti M, Heneghan C, Leota J, Hao S, Cimesa L, Cellini N, Overeem S, Baron KG, Sharafkhaneh A, Penzel T, Kushida CA. Sleep Med. 2026 Oct 31:109310. doi: 10.1016/j.sleep.2026.109310. PMID: 42869703

  • Journal Articles October 14, 2026
    Feasibility, Usability, and Promise of a Parent Management Training Using a Generative Artificial Intelligence Platform.

    Rivera-Cepeda CF, Vaclavik D, Bagner DM, Hardan AY, Bunge EL. Evid Based Pract Child Adolesc Ment Health. 2026;11(2):309-328. doi: 10.1080/23794925.2025.2602466. Epub 2025 Dec 15. PMID: 42847876

  • Journal Articles October 13, 2026
    Best practices for engaging lived experience experts in dialogues about climate change and mental health: lessons learned from a global effort.

    Wray B, Vercammen A, Zeitz L, Wright S, Burrows VE, Yamazaki J, Ali SJ, Hill K, Tiatia-Siau J, Wangmo K, Aruta JJB, Co G, Guinto RR, Lawrance EL. BMC Glob Public Health. 2026 Oct 13;4(1):100. doi: 10.1186/s44263-026-00321-7. PMID: 42870319

  • Journal Articles October 12, 2026
    Excitation-Inhibition Balance and Fronto-Limbic Connectivity Distinguish TMS Treatment Outcomes in Refractory Depression.

    Momi D, Wang Z, Oveisi MP, Kadak K, Bastiaens SP, Lissemore JI, Noda Y, Downar J, Rodriguez FV, Strafella R, Daskalakis ZJ, Zrenner C, Zomorrodi R, Rolle CE, Saggar M, Williams N, Keller CJ, Blumberger DM, Voineskos D, Griffiths JD. Biol Psychiatry. 2026 Oct 12:S0006-3223(26)01591-X. doi: 10.1016/j.biopsych.2026.09.027. PMID: 42863782

  • Journal Articles October 12, 2026
    Pediatric Inpatient Continuous Glucose Monitoring: Development and Implementation of a Hospital Policy for Accuracy-Validated Insulin Dosing.

    Lee MY, Ortega HI, Chow-Parmer C, Belanger K, Jones S, Ritter V, Chadwick W, Lee JJ, Kingston K, Suarez C, McGovern M, Maahs DM, Prahalad P, Shah S, Lal R, Hughes MS. Diabetes Technol Ther. 2026 Oct 12:15209156261489912. doi: 10.1177/15209156261489912. PMID: 42864817

  • Journal Articles October 11, 2026
    Prospective Predictors of Eating Disorder Duration and Transition to a Second Distinct Eating-Disorder Family in Adolescent Girls and Young Women.

    Imahori K, Yamamiya Y, Stice E. Int J Eat Disord. 2026 Oct 11. doi: 10.1002/eat.70240. PMID: 42860665

  • Journal Articles October 09, 2026
    Pregabalin in Dopamine Dysregulation Syndrome.

    Adler S, Fishbein D, Ng J. Mov Disord Clin Pract. 2026 Oct 9:10.1002/mdc3.70818. doi: 10.1002/mdc3.70818. PMID: 42852697

  • Journal Articles October 09, 2026
    Prediction of cardiovascular outcomes using electrocardiography from overnight polysomnography.

    Koscova Z, Nasiri S, Reyna MA, Bhatia NK, Rad AB, Sameni R, Sun H, Turley N, Katwa U, Hwang D, Stone KL, Trotti LM, Thomas RJ, Mignot E, Westover BM, Clifford GD. Sleep. 2026 Oct 9:zsag229. doi: 10.1093/sleep/zsag229. PMID: 42852996

  • Journal Articles October 08, 2026
    Optogenetics in Sight.

    Deisseroth K. N Engl J Med. 2026 Oct 8;395(14):1444-1446. doi: 10.1056/NEJMe2610388. PMID: 42842909

  • Journal Articles October 08, 2026
    Postural instability in individuals living with HIV infection: Relations with thalamic nuclei volumes, peripheral neuropathy, age, and falls.

    Fama R, Sassoon SA, Müller-Oehring EM, Saranathan M, Pohl KM, Zahr NM, Pfefferbaum A, Sullivan EV. J Acquir Immune Defic Syndr. 2026 Oct 8. doi: 10.1097/QAI.0000000000003983. PMID: 42842949

  • Journal Articles October 08, 2026
    Circadian biology in brain cancer diagnosis and treatment.

    Salvatore SV, Kaval AM, Gibson EM, Herzog ED. Neuro Oncol. 2026 Oct 8:noag179. doi: 10.1093/neuonc/noag179. PMID: 42844996

  • Journal Articles October 08, 2026
    Cerebellar Crus I and Crus II Structure and Excitation/Inhibition Balance in Autism Spectrum Disorder.

    Hegarty JP 2nd, Komaki H, Gu M, Young K, Ogbonnaya N, Spielman DM, Hardan AY. J Autism Dev Disord. 2026 Oct 8. doi: 10.1007/s10803-026-07529-4. PMID: 42848294

New Federally-Funded Projects

  • New Federal Funding October 02, 2026
    Stanford Psychiatry’s Tamar Green Awarded Grant Examining Brain Developmental Trajectories of Noonan Syndrome
  • New Federal Funding October 01, 2026
    Stanford Psychiatry’s Weidong Cai Awarded Grant to Research Volatility and Rigidity in Brain States
  • New Federal Funding September 30, 2026
    Stanford Psychiatry’s Mark McGovern on Multidisciplinary Team Researching Mobile Pharmacy and Clinic for Prevention, Care and Treatment of HIV and Substance Use
  • New Federal Funding September 22, 2026
    Stanford Psychiatry’s Feng Vankee Lin Awarded Grant Supporting Annual Brain Aging Workshops
  • New Federal Funding September 18, 2026
    New Stanford University center will use AI to tailor dementia treatments and aging interventions
  • New Federal Funding September 17, 2026
    Stanford Psychiatry’s Ivy Hoang Receives Grant to Research Extended Amygdala Cholecystokinin in Sleep Disturbances, Memory, and Addiction
  • New Federal Funding September 16, 2026
    Stanford Psychiatry’s Kilian Pohl Awarded Grant Researching Explainable AI for Predicting Incidents of Depression in People with HIV
  • New Federal Funding August 03, 2026
    Stanford’s Pervez Sultan and Debra Kaysen Awarded Grant Examining Early Intervention for Postpartum PTSD
  • New Federal Funding July 01, 2026
    Stanford Psychiatry's Yunji Park Receives Grant to Research Functional Brain Signatures of Learning Disabilities Across Development

Advancing Science

We are defining new approaches to treatment and prevention, seeking to cure psychiatric disorders and to foster overall health, wellbeing, and resilience.